GoodRx Holdings, Inc. reported $785M of revenue over the trailing twelve months, −1.8% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $785M (to Q2 2026). Net income: $16M, trailing twelve months to Q2 2026. Free cash flow: $197M, trailing twelve months to Q2 2026. Operating margin: 9.5%, trailing twelve months to Q2 2026.

GDRXGoodRx Holdings, Inc.

Healthcare

$3.38-23% 1Y

$3.38

$1.8752 weeks$4.64

GDRX as reported

GoodRx Holdings, Inc. reported $785M of revenue over the trailing twelve months, −1.8% on the year before. 11 reported series are charted on this page, each one as filed.

$785M

Revenue, trailing twelve months · to Q2 2026 · −1.8% against the twelve months before

Net income: $16M
Net income · −53% year on year · trailing twelve months to Q2 2026
Free cash flow: $197M
Free cash flow · +4.0% year on year · trailing twelve months to Q2 2026
Operating margin: 9.5%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for GDRX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$785M	−1.8%	Q2 2026
Net income	$16M	−53%	Q2 2026
EPS	$0.04	−60%	Q2 2026
Gross margin	91%	n/a	Q2 2026
Operating margin	9.5%	n/a	Q2 2026
Net margin	2.1%	n/a	Q2 2026
ROE	4.0%	n/a	Q2 2026
ROA	1.6%	n/a	Q2 2026
ROIC	7.6%	n/a	Q2 2026
Free cash flow	$197M	+4.0%	Q2 2026
P/E	84.5	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.